RS60017B1 - Halogenovani kvinazolin-thf-amini kao pde1 inhibitori - Google Patents
Halogenovani kvinazolin-thf-amini kao pde1 inhibitoriInfo
- Publication number
- RS60017B1 RS60017B1 RS20200239A RSP20200239A RS60017B1 RS 60017 B1 RS60017 B1 RS 60017B1 RS 20200239 A RS20200239 A RS 20200239A RS P20200239 A RSP20200239 A RS P20200239A RS 60017 B1 RS60017 B1 RS 60017B1
- Authority
- RS
- Serbia
- Prior art keywords
- thf
- amines
- pde1 inhibitors
- quinazolin
- halogenated
- Prior art date
Links
- 229940121836 Phosphodiesterase 1 inhibitor Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201400194 | 2014-04-04 | ||
| EP15713186.3A EP3126354B1 (en) | 2014-04-04 | 2015-03-27 | Halogenated quinazolin-thf-amines as pde1 inhibitors |
| PCT/EP2015/056713 WO2015150254A1 (en) | 2014-04-04 | 2015-03-27 | Halogenated quinazolin-thf-amines as pde1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS60017B1 true RS60017B1 (sr) | 2020-04-30 |
Family
ID=52779655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20200239A RS60017B1 (sr) | 2014-04-04 | 2015-03-27 | Halogenovani kvinazolin-thf-amini kao pde1 inhibitori |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US10005764B2 (sr) |
| EP (1) | EP3126354B1 (sr) |
| JP (1) | JP6554116B2 (sr) |
| KR (1) | KR20160138084A (sr) |
| CN (2) | CN106132953B (sr) |
| AP (1) | AP2016009521A0 (sr) |
| AR (1) | AR101155A1 (sr) |
| AU (1) | AU2015239696B2 (sr) |
| CA (1) | CA2943011A1 (sr) |
| CL (1) | CL2016002515A1 (sr) |
| CR (1) | CR20160463A (sr) |
| CY (1) | CY1122784T1 (sr) |
| DK (1) | DK3126354T3 (sr) |
| DO (1) | DOP2016000263A (sr) |
| EA (1) | EA032579B1 (sr) |
| EC (1) | ECSP16082599A (sr) |
| ES (1) | ES2776359T3 (sr) |
| GE (1) | GEP20186920B (sr) |
| GT (1) | GT201600213A (sr) |
| HR (1) | HRP20200369T1 (sr) |
| IL (1) | IL248078B (sr) |
| JO (1) | JO3628B1 (sr) |
| LT (1) | LT3126354T (sr) |
| MA (1) | MA39837B1 (sr) |
| MX (1) | MX364519B (sr) |
| PE (1) | PE20161380A1 (sr) |
| PH (1) | PH12016501938A1 (sr) |
| PL (1) | PL3126354T3 (sr) |
| PT (1) | PT3126354T (sr) |
| RS (1) | RS60017B1 (sr) |
| RU (1) | RU2692808C2 (sr) |
| SG (1) | SG11201608190YA (sr) |
| SI (1) | SI3126354T1 (sr) |
| SV (1) | SV2016005297A (sr) |
| TW (1) | TWI664178B (sr) |
| UA (1) | UA119166C2 (sr) |
| WO (1) | WO2015150254A1 (sr) |
| ZA (1) | ZA201606566B (sr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3126354T3 (pl) | 2014-04-04 | 2020-06-15 | H. Lundbeck A/S | Fluorowcowane chinazolino-THF-aminy jako inhibitory PDE1 |
| MX2019007803A (es) | 2016-12-28 | 2019-08-29 | Dart Neuroscience Llc | Compuestos de pirazolopirimidinona sustituida como inhibidores de fosfodiesterasas 2 (pde2). |
| ES2902365T3 (es) | 2017-11-27 | 2022-03-28 | Dart Neuroscience Llc | Compuestos de furanopirimidina sustituidos como inhibidores de PDE1 |
| CN117105809B (zh) * | 2023-10-20 | 2024-05-03 | 中国农业大学 | 一种苯甲酰苯胺化合物及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10042058A1 (de) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| GB0229281D0 (en) * | 2002-12-16 | 2003-01-22 | Novartis Ag | Organic compounds |
| ZA200507979B (en) * | 2003-03-03 | 2007-03-28 | Vertex Pharma Inc | Quinazolines useful as modulators of ion channels |
| GB0327319D0 (en) * | 2003-11-24 | 2003-12-24 | Pfizer Ltd | Novel pharmaceuticals |
| US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
| US20060183763A1 (en) * | 2004-12-31 | 2006-08-17 | Pfizer Inc | Novel pyrrolidyl derivatives of heteroaromatic compounds |
| JP2009527542A (ja) * | 2006-02-23 | 2009-07-30 | ファイザー・プロダクツ・インク | Ｐｄｅ１０阻害薬としての置換キナゾリン |
| US20070265258A1 (en) * | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| BR112012006615A2 (pt) * | 2009-09-24 | 2019-09-24 | Basf Se | compostos de amnoquinazolina da fórmula i, composição agrícola, composição veterinária, método material de propagação da planta, sementes e uso |
| US20130116241A1 (en) * | 2011-11-09 | 2013-05-09 | Abbvie Inc. | Novel inhibitor compounds of phosphodiesterase type 10a |
| TW201609713A (zh) * | 2013-12-19 | 2016-03-16 | Ｈ 朗德貝克公司 | 作爲ｐｄｅ１抑制劑之喹唑啉－ｔｈｆ－胺 |
| TW201611834A (en) | 2014-02-07 | 2016-04-01 | Lundbeck & Co As H | Hexahydrofuropyrroles as PDE1 inhibitors |
| PE20161407A1 (es) | 2014-04-04 | 2016-12-28 | Hoffmann La Roche | Piridina 5,6 disustituida -2-carboxamidas como agonistas del receptor canabinoide |
| AR099936A1 (es) | 2014-04-04 | 2016-08-31 | Sanofi Sa | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados |
| AR099937A1 (es) | 2014-04-04 | 2016-08-31 | Sanofi Sa | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados |
| MA39838B1 (fr) | 2014-04-04 | 2019-05-31 | Pfizer | Composés bicycliques hétéroaryle ou aryle fusionnés et leur utilisation en tant qu'inhibiteurs irak4 |
| JP6654574B2 (ja) | 2014-04-04 | 2020-02-26 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｃｂ２アゴニストとして有用なピリジン−２−アミド |
| PL3126354T3 (pl) | 2014-04-04 | 2020-06-15 | H. Lundbeck A/S | Fluorowcowane chinazolino-THF-aminy jako inhibitory PDE1 |
-
2015
- 2015-03-27 PL PL15713186T patent/PL3126354T3/pl unknown
- 2015-03-27 SG SG11201608190YA patent/SG11201608190YA/en unknown
- 2015-03-27 RU RU2016138743A patent/RU2692808C2/ru active
- 2015-03-27 US US15/301,210 patent/US10005764B2/en active Active
- 2015-03-27 DK DK15713186.3T patent/DK3126354T3/da active
- 2015-03-27 PE PE2016001906A patent/PE20161380A1/es unknown
- 2015-03-27 LT LTEP15713186.3T patent/LT3126354T/lt unknown
- 2015-03-27 CA CA2943011A patent/CA2943011A1/en not_active Abandoned
- 2015-03-27 SI SI201531112T patent/SI3126354T1/sl unknown
- 2015-03-27 AP AP2016009521A patent/AP2016009521A0/en unknown
- 2015-03-27 UA UAA201610191A patent/UA119166C2/uk unknown
- 2015-03-27 CN CN201580017454.2A patent/CN106132953B/zh active Active
- 2015-03-27 AU AU2015239696A patent/AU2015239696B2/en not_active Ceased
- 2015-03-27 EP EP15713186.3A patent/EP3126354B1/en active Active
- 2015-03-27 PT PT157131863T patent/PT3126354T/pt unknown
- 2015-03-27 GE GEAP201514286A patent/GEP20186920B/en unknown
- 2015-03-27 CN CN201910110735.2A patent/CN109999039A/zh active Pending
- 2015-03-27 CR CR20160463A patent/CR20160463A/es unknown
- 2015-03-27 ES ES15713186T patent/ES2776359T3/es active Active
- 2015-03-27 EA EA201691773A patent/EA032579B1/ru not_active IP Right Cessation
- 2015-03-27 MX MX2016012955A patent/MX364519B/es active IP Right Grant
- 2015-03-27 KR KR1020167027262A patent/KR20160138084A/ko not_active Application Discontinuation
- 2015-03-27 RS RS20200239A patent/RS60017B1/sr unknown
- 2015-03-27 JP JP2016560728A patent/JP6554116B2/ja active Active
- 2015-03-27 WO PCT/EP2015/056713 patent/WO2015150254A1/en active Application Filing
- 2015-03-27 MA MA39837A patent/MA39837B1/fr unknown
- 2015-03-30 JO JOP/2015/0058A patent/JO3628B1/ar active
- 2015-03-31 TW TW104110439A patent/TWI664178B/zh not_active IP Right Cessation
- 2015-04-01 AR ARP150101009A patent/AR101155A1/es unknown
-
2016
- 2016-09-22 ZA ZA2016/06566A patent/ZA201606566B/en unknown
- 2016-09-27 DO DO2016000263A patent/DOP2016000263A/es unknown
- 2016-09-27 IL IL248078A patent/IL248078B/en active IP Right Grant
- 2016-09-29 PH PH12016501938A patent/PH12016501938A1/en unknown
- 2016-10-03 CL CL2016002515A patent/CL2016002515A1/es unknown
- 2016-10-03 SV SV2016005297A patent/SV2016005297A/es unknown
- 2016-10-03 GT GT201600213A patent/GT201600213A/es unknown
- 2016-10-20 EC ECIEPI201682599A patent/ECSP16082599A/es unknown
-
2018
- 2018-06-13 US US16/007,561 patent/US10526319B2/en active Active
-
2020
- 2020-03-04 HR HRP20200369TT patent/HRP20200369T1/hr unknown
- 2020-03-04 CY CY20201100196T patent/CY1122784T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287113A (en) | smyd inhibitors | |
| IL251420A0 (en) | Triazolopyrazinones as pde1 inhibitors | |
| HK1249097A1 (zh) | 作為pde1抑制劑的咪唑並三嗪酮 | |
| GB2531928B (en) | Image-stitching for dimensioning | |
| IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
| GB201817189D0 (en) | Image-stitching for dimensioning | |
| HK1252098B (zh) | 作為pde1抑制劑的咪唑並吡嗪酮 | |
| HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
| IL248895A0 (en) | Phosphatidylinositol 3-kinase inhibitors | |
| IL252866A0 (en) | History of imidazopyridazine as pi3kbeta inhibitors | |
| IL248078B (en) | Halogenated thf quinazoline amines as pde1 inhibitors | |
| HK1232214A1 (zh) | 作為 抑制劑的六氫呋喃並吡咯 | |
| IL249075B (en) | agent for fluoroalkylation | |
| HK1226296A1 (zh) | 用於產生視黃酸的試劑 | |
| GB201418154D0 (en) | Inhibitors | |
| GB201407865D0 (en) | Nucleases |